Geron Corporation (GERN)

1.47 +0.05 (+3.521%)

IEX Real-Time Price

February 15, 2019 EST.

Nasdaq Global Select : Healthcare

Prev Close 1.42

Price Open 1.42

Volume: 3.32M

Avg Volume: 3.02M

Market Cap: 273.93M

P/E Ratio -9.19

52 Wk Range 0.9547-6.99



GERN Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-10-15
178.62M
34.42M
2.61
19.27%

2018-09-28
178.62M
60.64M
4.16
33.95%

2018-09-14
178.62M
63.43M
6.66
35.51%

2018-08-31
178.62M
62.9M
9.73
35.21%




GERN Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-11-01
Q3 2018
AMC
-0.05 (1)
-0.03
0.02

2018-07-31
Q2 2018
AMC
-0.04 (1)
-0.04
0.00

2018-05-10
Q1 2018
N/A
0.00 (0)
-0.04
0.00

2018-05-08
Q1 2018
N/A
-0.04 (1)
0.00
0.00

News

SOLO, DBD among premarket gainers (2019-02-13 09:19 SeekingAlpha)

Electrameccanica Vehicles (NASDAQ: SOLO ) +37% . More news on: Electrameccanica Vehicles Corp. Ltd., Diebold Nixdorf, Criteo S.A., Stocks on the move, Read more …

 

Piper likes OncoCyte in premarket analyst action (2019-02-13 07:35 SeekingAlpha)

OncoCyte (NYSEMKT: OCX ) initiated with Buy rating and $6 (56% upside) price target at Piper Jaffray. Shares up 7% premarket. More news on: OncoCyte Corporation, Clovis Oncology, Galectin Therapeutics, Inc., Healthcare stocks news, , Stocks on the move, Read more …

 


Statistics

Shares Outstanding: 186.35M

Top 15 Institution Percent: 54.10

Price To Sales: 353.28

Price To Book: 1.31

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -18.04

Return On Equity: -18.68

Profit Margin: N/A

Price History

Beta: 2.90

50-day Moving Avg: 1.21

200-day Moving Avg: 2.90

YTD Change: 36.54

5-day Change: 9.23

1-month Change: 30.28

3-month Change: -5.96

6-month Change: -63.68

1-year Change: -37.99

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Geron Corporation

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.geron.com

Geron Corp is a biopharmaceutical company. It supports the clinical stage development of a telomerase inhibitor, imetelstat.